CODX vs CSGP
Co-Diagnostics, Inc. Common Stock (CODX) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
CODX currently screens at market cap $31.4M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the CODX and CSGP stock pages for the full models.
Not investment advice.